Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Health Sciences Group Appoints New CEO
Company's Board of Directors has appointed Stuart Gold as its Chief Executive Officer.
- Lifeway Foods Reports Record Second Quarter 2006 Sales Results
Company reports sales of $6,365,147 compared to $5,072,567 during the same period a year ago.
- Lifeway Foods Reports Record Second Quarter 2006 Sales Results
Company reports sales of $6,365,147 compared to $5,072,567 during the same period a year ago.
- Huber Engineered Materials Acquires West Coast Ingredients
Huber Engineered Materials, part of J.M. Huber Corporation, today announced the acquisition of West Coast Ingredients in Modesto, Calif. Terms of the deal were not released.
- Huber Engineered Materials Acquires West Coast Ingredients
Huber Engineered Materials, part of J.M. Huber Corporation, today announced the acquisition of West Coast Ingredients in Modesto, Calif. Terms of the deal were not released.
- Natrol Elects James Peters to Its Board of Directors
Company has announced the election of James R. Peters to its Board of Directors. Mr. Peters is expected to be named Chairman of the Audit Committee.
- Natrol Elects James Peters to Its Board of Directors
Company has announced the election of James R. Peters to its Board of Directors. Mr. Peters is expected to be named Chairman of the Audit Committee.
- Natrol Elects James Peters to Its Board of Directors
Company has announced the election of James R. Peters to its Board of Directors. Mr. Peters is expected to be named Chairman of the Audit Committee.
- Natrol Elects James Peters to Its Board of Directors
Company has announced the election of James R. Peters to its Board of Directors. Mr. Peters is expected to be named Chairman of the Audit Committee.
- Natural Alternatives International, Inc. Announces Fourth Quarter Sales Results and Changes to Executive Team
Company announces net sales in excess of $33 million for the three months ended June 30, 2006, surpassing the previous quarterly net sales record set in the fourth quarter of fiscal 2005, and that John Dullea has assumed additional responsibilities as Executive Vice President of NAI and will be responsible for all sales and marketing activities of NAI. Tim Belanger, former Senior Vice President - Sales and Marketing, and Mark Zimmerman, former Vice President - Operations, are no longer with the company.
- Natural Alternatives International, Inc. Announces Fourth Quarter Sales Results and Changes to Executive Team
Company announces net sales in excess of $33 million for the three months ended June 30, 2006, surpassing the previous quarterly net sales record set in the fourth quarter of fiscal 2005, and that John Dullea has assumed additional responsibilities as Executive Vice President of NAI and will be responsible for all sales and marketing activities of NAI. Tim Belanger, former Senior Vice President - Sales and Marketing, and Mark Zimmerman, former Vice President - Operations, are no longer with the company.
- Nutratech, Inc., Files Patent Infringement Lawsuit
Company has filed a patent infringement lawsuit against Syntech International, a nutraceutical ingredient supplier based in Walnut, Calif.
- Nutratech, Inc., Files Patent Infringement Lawsuit
Company has filed a patent infringement lawsuit against Syntech International, a nutraceutical ingredient supplier based in Walnut, Calif.
- Cognis Completes Acquisition of Omega-3 Fish Oil Company
Company has completed the acquisition of Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry.
- Cognis Completes Acquisition of Omega-3 Fish Oil Company
Company has completed the acquisition of Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry.
- Cognis Completes Acquisition of Omega-3 Fish Oil Company
Company has completed the acquisition of Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry.
- Cognis Completes Acquisition of Omega-3 Fish Oil Company
Company has completed the acquisition of Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry.
- Cognis Completes Acquisition of Omega-3 Fish Oil Company
Company has completed the acquisition of Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry.
- New Patent Promotes Soy Isoflavone Benefits
The U.S. Patent Office has issued patent number 7,045,155 to Novogen, Ltd; This patent, which Acatris has exclusively licensed, protects compositions for the amelioration of human health conditions that are responsive to treatment with phyto-estrogens. The compositions comprise phytoestrogen-enriched extracts primarily from soy hypocotyls.
- New Patent Promotes Soy Isoflavone Benefits
The U.S. Patent Office has issued patent number 7,045,155 to Novogen, Ltd; This patent, which Acatris has exclusively licensed, protects compositions for the amelioration of human health conditions that are responsive to treatment with phyto-estrogens. The compositions comprise phytoestrogen-enriched extracts primarily from soy hypocotyls.
- New Patent Promotes Soy Isoflavone Benefits
The U.S. Patent Office has issued patent number 7,045,155 to Novogen, Ltd; This patent, which Acatris has exclusively licensed, protects compositions for the amelioration of human health conditions that are responsive to treatment with phyto-estrogens. The compositions comprise phytoestrogen-enriched extracts primarily from soy hypocotyls.
- Dynamic Health Products, Inc. Reports 2006 Revenue
Company reports revenues of $50.1 million, an increase of 212% over the prior year's revenues of $16.1 million, with net income applicable to common shareholders of $5.9 million compared to a net loss of $4.4 million in the prior year.
- Dynamic Health Products, Inc. Reports 2006 Revenue
Company reports revenues of $50.1 million, an increase of 212% over the prior year's revenues of $16.1 million, with net income applicable to common shareholders of $5.9 million compared to a net loss of $4.4 million in the prior year.
- Schiff Nutrition International, Inc. Announces Fiscal 2006 Fourth Quarter and Year-End Results
Company reports net sales of $45.3 million for the three months ended May 31, 2006, compared to $39.9 million for the same period in fiscal 2005, with net income of $6.2 million, or $0.23 per diluted share, versus a net loss of ($1.8) million, or ($0.07) per share, which included an after-tax loss from discontinued operations of ($5.7) million for the same period a year ago.
- Schiff Nutrition International, Inc. Announces Fiscal 2006 Fourth Quarter and Year-End Results
Company reports net sales of $45.3 million for the three months ended May 31, 2006, compared to $39.9 million for the same period in fiscal 2005, with net income of $6.2 million, or $0.23 per diluted share, versus a net loss of ($1.8) million, or ($0.07) per share, which included an after-tax loss from discontinued operations of ($5.7) million for the same period a year ago.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- Galaxy Nutritional Foods Reports FY2006 Operating Results
For the quarter, company reports a net loss of ($1,833,320), or ($0.09) per share, on net sales of approximately $8.4 million, compared with a net loss of ($2,545,790), or ($0.14) per share, and net sales of approximately $10.8 million, in the fourth quarter of the previous fiscal year.
- Galaxy Nutritional Foods Reports FY2006 Operating Results
For the quarter, company reports a net loss of ($1,833,320), or ($0.09) per share, on net sales of approximately $8.4 million, compared with a net loss of ($2,545,790), or ($0.14) per share, and net sales of approximately $10.8 million, in the fourth quarter of the previous fiscal year.
- Enzymotec and Il Dong Sign Agreement in the Korean Market
Israeli biotech company Enzymotec and Korean pharmaceuticals manufacturer Il Dong have announced signing an agreement to launch a novel supplement for CVD prevention in the Korean market.
- Enzymotec and Il Dong Sign Agreement in the Korean Market
Israeli biotech company Enzymotec and Korean pharmaceuticals manufacturer Il Dong have announced signing an agreement to launch a novel supplement for CVD prevention in the Korean market.
- Natural Products Association Announces Opening of China Office
Association announces the opening of a branch office in Beijing, China to better assist the U.S. companies that hope to export their products to this booming marketplace.
- Natural Products Association Announces Opening of China Office
Association announces the opening of a branch office in Beijing, China to better assist the U.S. companies that hope to export their products to this booming marketplace.
- Natural Products Association Announces Opening of China Office
Association announces the opening of a branch office in Beijing, China to better assist the U.S. companies that hope to export their products to this booming marketplace.
- Natural Products Association Announces Opening of China Office
Association announces the opening of a branch office in Beijing, China to better assist the U.S. companies that hope to export their products to this booming marketplace.
- UTEK Corporation and Gadot Biochemical Industries, Ltd. Announce Strategic Alliance
Companies announce that they have signed a strategic alliance agreement. In line with its strategic goal to develop innovative solutions for the fortification and supplement industry, Gadot is seeking new technologies to produce new health ingredients as well as to improve its current production processes.
- UTEK Corporation and Gadot Biochemical Industries, Ltd. Announce Strategic Alliance
Companies announce that they have signed a strategic alliance agreement. In line with its strategic goal to develop innovative solutions for the fortification and supplement industry, Gadot is seeking new technologies to produce new health ingredients as well as to improve its current production processes.
- UTEK Corporation and Gadot Biochemical Industries, Ltd. Announce Strategic Alliance
Companies announce that they have signed a strategic alliance agreement. In line with its strategic goal to develop innovative solutions for the fortification and supplement industry, Gadot is seeking new technologies to produce new health ingredients as well as to improve its current production processes.
- UTEK Corporation and Gadot Biochemical Industries, Ltd. Announce Strategic Alliance
Companies announce that they have signed a strategic alliance agreement. In line with its strategic goal to develop innovative solutions for the fortification and supplement industry, Gadot is seeking new technologies to produce new health ingredients as well as to improve its current production processes.
- USANA Reports Q2 Results
Company reports consolidated net sales of $93.9 million, compared with $82.0 million in the second quarter of the prior year, with net earnings of $15.4 million, or 16.4% of net sales, compared with $14.7 million, or 18.0% of net sales, in the second quarter of the prior year.
- USANA Reports Q2 Results
Company reports consolidated net sales of $93.9 million, compared with $82.0 million in the second quarter of the prior year, with net earnings of $15.4 million, or 16.4% of net sales, compared with $14.7 million, or 18.0% of net sales, in the second quarter of the prior year.
- Allimax Enters Australia
Company announces strategic partnership with Vitasearch PTY LTD. Waterloo, NSW for the development and marketing of its Allimax stabilized allicin extract brand of supplements.
- Allimax Enters Australia
Company announces strategic partnership with Vitasearch PTY LTD. Waterloo, NSW for the development and marketing of its Allimax stabilized allicin extract brand of supplements.
- Leiner Health Products Appoints Kevin McDonnell Executive Vice President, Chief Financial Officer
Company announces the appointment of Kevin McDonnell to the position of Executive Vice President, Chief Financial Officer.
- Leiner Health Products Appoints Kevin McDonnell Executive Vice President, Chief Financial Officer
Company announces the appointment of Kevin McDonnell to the position of Executive Vice President, Chief Financial Officer.
- Leiner Health Products Appoints Kevin McDonnell Executive Vice President, Chief Financial Officer
Company announces the appointment of Kevin McDonnell to the position of Executive Vice President, Chief Financial Officer.
- Leiner Health Products Appoints Kevin McDonnell Executive Vice President, Chief Financial Officer
Company announces the appointment of Kevin McDonnell to the position of Executive Vice President, Chief Financial Officer.
- Fuji Chemical Granted Inflammation Patent For Astaxanthin
Fuji Chemical Industry Co., Ltd. has been granted U.S. Patent No. 7,078,040, which involves inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxnathin.
- Fuji Chemical Granted Inflammation Patent For Astaxanthin
Fuji Chemical Industry Co., Ltd. has been granted U.S. Patent No. 7,078,040, which involves inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxnathin.
- Fuji Chemical Granted Inflammation Patent For Astaxanthin
Fuji Chemical Industry Co., Ltd. has been granted U.S. Patent No. 7,078,040, which involves inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxnathin.
- Fortitech South America Adds Staff to Address Rapid Premix Sales Growth
Fortitech South America has increased its workforce by hiring Rafael Leite as its newest regional sales manager. Leite, who will focus on all Spanish-speaking countries in South America
- Fortitech South America Adds Staff to Address Rapid Premix Sales Growth
Fortitech South America has increased its workforce by hiring Rafael Leite as its newest regional sales manager. Leite, who will focus on all Spanish-speaking countries in South America
- NSF Vice President Named Adjunct Assistant Professor for Michigan State University
NSF Vice President Named Adjunct Assistant Professor for MSU’s Food Science and Human Nutrition Department
- NSF Vice President Named Adjunct Assistant Professor for Michigan State University
NSF Vice President Named Adjunct Assistant Professor for MSU’s Food Science and Human Nutrition Department
- Lifeway Foods Acquires Helios Kefir
Company announces the acquisition of Helios Nutrition Limited, its top competitor in the kefir market with a #2 overall market share and a #1 position in the organic category.
- Lifeway Foods Acquires Helios Kefir
Company announces the acquisition of Helios Nutrition Limited, its top competitor in the kefir market with a #2 overall market share and a #1 position in the organic category.
- NBTY Reports Third Quarter Results
Company reports net sales of $475 million, including $24 million generated by Solgar, compared to net sales of $439 million for the fiscal third quarter prior year, with net income of $30 million, or $0.43 per diluted share, compared to $16 million, or $0.23 per diluted share, for the fiscal third quarter ended June 30, 2005.
- NBTY Reports Third Quarter Results
Company reports net sales of $475 million, including $24 million generated by Solgar, compared to net sales of $439 million for the fiscal third quarter prior year, with net income of $30 million, or $0.43 per diluted share, compared to $16 million, or $0.23 per diluted share, for the fiscal third quarter ended June 30, 2005.
- Nutraceutical Reports Sales and Income
Company reports net sales for the fiscal 2006 third quarter of $37.0 million compared to $37.2 million for the same quarter prior year, with net income of $3.4 million, or $0.29 diluted earnings per share, compared to $3.2 million, or $0.27 diluted earnings per share, for the same quarter of fiscal 2005.
- Nutraceutical Reports Sales and Income
Company reports net sales for the fiscal 2006 third quarter of $37.0 million compared to $37.2 million for the same quarter prior year, with net income of $3.4 million, or $0.29 diluted earnings per share, compared to $3.2 million, or $0.27 diluted earnings per share, for the same quarter of fiscal 2005.
- Natural Health Trends Appoints Stephanie S. Hayano President and CEO
Company announces the appointment of Stephanie S. Hayano as President and Chief Executive Officer, effective July 31.
- Natural Health Trends Appoints Stephanie S. Hayano President and CEO
Company announces the appointment of Stephanie S. Hayano as President and Chief Executive Officer, effective July 31.
- Natural Health Trends Appoints Stephanie S. Hayano President and CEO
Company announces the appointment of Stephanie S. Hayano as President and Chief Executive Officer, effective July 31.
- Natural Health Trends Appoints Stephanie S. Hayano President and CEO
Company announces the appointment of Stephanie S. Hayano as President and Chief Executive Officer, effective July 31.
- GNC Corporation Files Registration Statement With SEC for IPO
Company announces it filed an amended registration statement with the Securities and Exchange Commission for the initial public offering of its common stock. A total of 23,530,000 shares of common stock are to be sold in the offering, with approximately 9.4 million new shares to be offered by GNC and approximately 14.1 million shares to be sold by its principal stockholder.
- GNC Corporation Files Registration Statement With SEC for IPO
Company announces it filed an amended registration statement with the Securities and Exchange Commission for the initial public offering of its common stock. A total of 23,530,000 shares of common stock are to be sold in the offering, with approximately 9.4 million new shares to be offered by GNC and approximately 14.1 million shares to be sold by its principal stockholder.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Pagosa Springs, CO – July 14, 2006 – NZyme Pharmaceuticals, Inc. (d/b/a NZyme Pharm) announced today that they have a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease such as heart attacks and ischemic strokes, essential hypertension and deep vein thrombosis.
Subtilisin NAT is a pro-fibrinolytic enzyme that is present in a vegetable cheese-like food called Natto, which is extremely popular in Japan and has been consumed for over 1,000 years. Natto is prepared by fermenting boiled soybeans with Bacillus spp. (e.g., Bacillus subtilis in particular Bacillus subtilis var. natto). Traditionally, Natto was consumed as a folk remedy to treat various conditions and ailments. Subtilisin NAT may be extracted and purified from Natto.
“The new patent will be a timely arrival for the medical community as recent clinical research shows an increasing risk-to-benefit ratio with cardiovascular patients taking aspirin.” said Ralph E. Holsworth, Jr., D.O., co-founder of NZyme Pharm and director of clinical and scientific research. “With over three hundred independent cardiac risk factors, whole blood viscosity has been clinically proven to be the common denominator of vascular disease.”
NZyme brand for oral administration is provided in the form of a softchew and medical bar. All ingredients are 100% organic and non-Genetic Modified Organism (non-GMO). All prescribed medical foods contain 100 mg of Subtilisin NAT which is the fibrinolytic equivalent greater than 2,000 fibrinolytic units (FUs).
About NZyme Pharmaceuticals, Inc.
NZyme Pharmaceuticals, Inc. (NZyme Pharm) has an exclusive license to market enzymes and co-enzymes that have been clinically proven to address the etiology of disease or dysfunction. By going to the cause of the disease process and treating it on a functional basis (such as increased blood viscosity) the disease has a higher incidence of being managed or prevented. The products at NZyme Pharm re-establish fundamental cellular conditions that help people find their way back to health.
# # #
|